JPRN-UMIN000004847已完成未知
The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplasty - The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplasty
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
Oral presentation at The 37th Annual Meeting of Japanese Hip Society
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Metabolic bone disease except for osteopolosis, taking medications that could affect bone turnover (such as bisphosphonates, active vitamin D3, estrogen, calcitonin, SERM, ipriphrabones, vitamin K), renal disfunction.
研究者
相似试验
已完成
3 期
Effect of Alendronate in Patents with Osteoporosis and Chronic Kidney DiseaseChronic Kidney Disease Stage 3a-3b.Chronic kidney disease, stage 3 (moderate)IRCT20180506039549N1Ahvaz University of Medical Sciences82
已完成
2 期
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile OsteoporosisOsteoporosisNCT00010439Medical University of South Carolina10
已完成
不适用
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related OsteoporosisCystic FibrosisOsteoporosisNCT00004489University of North Carolina60
已完成
2 期
Alendronate and/or Parathyroid Hormone for OsteoporosisOsteoporosisNCT00000400Massachusetts General Hospital176
已完成
4 期
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal WomenOsteopeniaOsteoporosisNCT00504166University of California, San Francisco53